Mr. Siqi Fu is a managing partner of Tian Yuan Law Firm, and the person in charge of Tian Yuan Law Firm Hong Kong Office. Mr. Fu focuses on the Capital markets, especially the overseas IPO area. Since 2017, Mr. Fu has completed 15 overseas IPO deals, among which, the most significant deals are as below: Qudian (QD.Nasdaq) –the largest IPO in the history of Chinese concept shares to list in the United States in the Fintech industry; Bilibili Inc. (BILI, Nasdaq); 7 Road Holdings Limited (00797. HK); Ascletis Pharma Inc. (01672. HK)- the first biotech pharmaceutical company to list on The Hong Kong Stock Exchange after the amendment of The Hong Kong Main Board Listing Rules on biotech companies and C-MER Eye Care Holdings Limited（3309.HK）.
Mr. Fu has worked at Jingtian & Gongcheng since 2002 and works at Tian Yuan from 2016.